WA
JAZZ icon

WPG Advisers’s Jazz Pharmaceuticals JAZZ Stock Holding History

WPG Advisers’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$64.3K Sell
340
-14
-4% -$2.45K 0.05% 226
2025
Q4 		$60.2K Sell
354
-11
-3% -$1.69K 0.04% 255
2025
Q3 		$48.1K Buy
365
+30
+9% +$3.6K 0.04% 299
2025
Q2 		$35.5K Buy
335
+275
+458% +$29.9K 0.03% 354
2025
Q1 		$7.45K Buy
60
+37
+161% +$4.83K 0.01% 737
2024
Q4 		$2.83K Buy
+23
New +$2.71K ﹤0.01% 997

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

WPG Advisers's JAZZ Position: Q1 2026 in Review

WPG Advisers reduced its Jazz Pharmaceuticals (JAZZ) stake by 4% in Q1 2026, selling an estimated $2.45K and leaving 340 shares worth $64.3K. The position accounts for 0.05% of the portfolio, ranked #226.

WPG Advisers first reported a position in JAZZ in Q4 2024 and has held it in 6 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • WPG Advisers held 340 shares of Jazz Pharmaceuticals worth $64.3K as of Q1 2026.
  • WPG Advisers sold 14 Jazz Pharmaceuticals shares in Q1 2026, an estimated $2.45K.
  • Jazz Pharmaceuticals made up 0.05% of WPG Advisers's portfolio in Q1 2026, its #226 holding.
  • WPG Advisers first reported a position in Jazz Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on WPG Advisers's 13F filing for Q1 2026, filed 30 Apr 2026.